-
Vericel (VCEL) Tops Q4 EPS by 6c
-
Vericel reports preliminary 2025 revenue of $276 million
-
BTIG Reiterates Neutral Rating on Vericel Corporation (VCEL)
-
Vericel (VCEL) Tops Q3 EPS by 11c, Beats on Revenue; Offers FY25 Revenue Guidance
-
BTIG Downgrades Vericel Corporation (VCEL) to Neutral
-
TD Cowen Reiterates Buy Rating on Vericel Corporation (VCEL)
-
Vericel Corporation (VCEL) PT Lowered to $58 at Canaccord Genuity
-
Vericel (VCEL) Tops Q2 EPS by 2c
-
BTIG Reiterates Buy Rating on Vericel Corporation (VCEL)
-
Canaccord Genuity Reiterates Buy Rating on Vericel Corporation (VCEL)
-
Truist Securities Reiterates Buy Rating on Vericel Corporation (VCEL)
-
Vericel (VCEL) mentioned cautiously at Off Wall Street
-
TD Cowen on Medical Supplies & Devices: 'Companies Least Affected by New Reciprocal Tariffs'
-
Vericel Corporation (VCEL) PT Lowered to $61 at Truist Securities
-
Vericel Corporation (VCEL) PT Raised to $67 at Canaccord Genuity
-
H.C. Wainwright Reiterates Buy Rating on Vericel Corporation (VCEL)
-
Canaccord Genuity Reiterates Buy Rating on Vericel Corporation (VCEL)
-
Vericel (VCEL) Announces Preliminary 2024 Financial Results, 2025 Financial Guidance and Increased Mid-Term Profitability Targets
-
Vericel Corporation (VCEL) PT Raised to $67 at Truist Securities, Citing '20%+ Growth Prospects'
-
Vericel Corporation (VCEL) PT Raised to $72 at TD Cowen; 'The Launch of MACI Arthro Is a Key Lever to Long-Term Growth'
-
Vericel Corporation (VCEL) PT Raised to $56 at BTIG
-
Canaccord Genuity Reiterates Buy Rating on Vericel Corporation (VCEL)
-
Vericel (VCEL) Tops Q3 EPS by 3c
-
Vericel Corporation (VCEL) PT Raised to $60 at TD Cowen
-
BTIG Reiterates Buy Rating on Vericel Corporation (VCEL)
-
Vericel (VCEL) Announces FDA Approval and Commercial Availability of MACI Arthro
-
Vericel (VCEL) Files Mixed Shelf
-
TD Cowen Reiterates Buy Rating on Vericel Corporation (VCEL)
-
Vericel (VCEL) Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal Burns
-
Canaccord Genuity Starts Vericel Corporation (VCEL) at Buy
-
Vericel Corporation (VCEL) PT Raised to $58 at Stephens
-
Vericel Corporation (VCEL) PT Raised to $60 at H.C. Wainwright
-
Vericel (VCEL) Misses Q2 EPS by 1c
-
BTIG Reiterates Buy Rating on Vericel Corporation (VCEL)
-
TD Cowen Reiterates Buy Rating on Vericel Corporation (VCEL)
-
TD Cowen Starts Vericel Corporation (VCEL) at Buy

